Motif Neurotech, a company specialising in bioelectronics for mental health, has raised $18.75m in a series A funding round. The money will be used to advance clinical development of its DOT microstimulator, a device designed to treat treatment-resistant depression (TRD) by stimulating specific brain circuits. The funding will also help the company enhance the device, scale production and distribution.
Sure, Why Not: Windows 11 AI Agents Might Install Malware On Your PC – aftermath.site
Sure, Why Not: Windows 11 AI Agents Might Install Malware On Your PC aftermath.site
